ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

PHAT Phathom Pharmaceuticals Inc

9.86
0.10 (1.02%)
最終更新日: 02:49:15
15分遅延
名称 銘柄コード 市場 種別
Phathom Pharmaceuticals Inc PHAT NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.10 1.02% 9.86 02:49:15
始値 安値 高値 終値 前日終値
10.35 9.85 10.37 9.76
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2921:00GLOBEPhathom Pharmaceuticals to Report First Quarter 2024..
2024/4/0321:00GLOBEPhathom Pharmaceuticals to Participate in the 23rd Annual..
2024/3/2621:00GLOBEPhathom Pharmaceuticals Launches Direct-to-Consumer..
2024/3/0806:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0722:06EDGAR2Form 8-K - Current report
2024/3/0722:00GLOBEPhathom Pharmaceuticals Reports Fourth Quarter and Full Year..
2024/2/2922:00GLOBEPhathom Pharmaceuticals to Report Fourth Quarter and Full..
2024/2/1322:05EDGAR2Form 8-K - Current report
2024/2/1322:00GLOBEPhathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan)..
2024/1/3122:00GLOBEPhathom Pharmaceuticals to Present at the Guggenheim..
2024/1/2310:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1606:05EDGAR2Form 8-K - Current report
2023/12/1422:05EDGAR2Form 8-K - Current report
2023/12/1422:00GLOBEPhathom Pharmaceuticals Announces Expansion of Existing Loan..
2023/12/0622:05EDGAR2Form 8-K - Current report
2023/12/0622:00GLOBEPhathom Pharmaceuticals Announces FDA Acceptance for Filing..
2023/11/2822:06EDGAR2Form 8-K - Current report
2023/11/2822:00GLOBEPhathom Pharmaceuticals Announces Commercial Availability of..
2023/11/2014:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/1006:02EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/0922:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0922:05EDGAR2Form 8-K - Current report
2023/11/0922:00GLOBEPhathom Pharmaceuticals Reports Third Quarter 2023 Results..
2023/11/0909:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0405:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0206:50DJNPhathom Pharmaceuticals Gets FDA Approval for Voquezna..
2023/11/0206:06EDGAR2Form 8-K - Current report
2023/11/0206:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®..
2023/10/3021:05EDGAR2Form 8-K - Current report
2023/10/3021:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of..
2023/10/2521:01GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
2023/9/2621:05EDGAR2Form 8-K - Current report
2023/9/2621:01GLOBEPhathom Pharmaceuticals Announces Vonoprazan NDA Submission..
2023/9/0521:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
2023/8/2121:07EDGAR2Form 8-K - Current report
2023/8/2121:00GLOBEPhathom Pharmaceuticals Announces Submission of Six-Month..
2023/8/1105:02EDGAR2Form 8-K - Current report
2023/8/1021:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1021:01GLOBEPhathom Pharmaceuticals Reports Second Quarter 2023 Results
2023/7/1806:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1805:04EDGAR2Form 8-K - Current report
2023/7/1805:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2023/6/1222:04DJNFDA Accepts Phathom Pharmaceuticals' Resubmission for..
2023/6/1221:01GLOBEPhathom Pharmaceuticals Announces FDA Acceptance of NDA..
2023/6/1005:01GLOBEPhathom Pharmaceuticals Announces Closing of Underwriters’..
2023/6/0918:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
2023/6/0718:45PRNUSINVESTIGATION ALERT: The Gross Law Firm Notifies..
2023/6/0218:45PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..
2023/6/0121:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
2023/5/3018:00PRNUSPHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom..

最近閲覧した銘柄

Delayed Upgrade Clock